Imagen de Portada

Safety and effects of acetylated and butyrylated high‐amylose maize starch on youths recently diagnosed with type 1 diabetes: A pilot study

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Heba M. Ismail, Jianyun Liu, Michael Netherland, Nur A. Hasan, Carmella Evans‐Molina, Linda A. DiMeglio
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Diabetes, Obesity and Metabolism
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Type 1 diabetes presenting in adults: Trends, diagnostic challenges and unique features
por: Carmella Evans‐Molina, et al.
Publicado: (2025)

Glycaemic treatment of newly diagnosed type 2 diabetes
por: Mayer B. Davidson
Publicado: (2024)

Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh
por: Muhammad Hafizur Rahman, et al.
Publicado: (2025)

Could continuous subcutaneous glucose sensors ( CGMS ) be repurposed to diagnose diabetes in equivocal or challenging cases?
por: Martin B. Whyte, et al.
Publicado: (2025)

Modelling and assessment of glucose‐lactate kinetics in youth with overweight, obesity and metabolic dysfunction‐associated steatotic liver disease: A pilot study
por: Jacopo Bonet, et al.
Publicado: (2024)

Association between recent exposure to continuous glucose monitoring‐recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes
por: Cecilie H. Svensson, et al.
Publicado: (2024)

Low levels of soluble neuropilin‐1 were associated with depression in adults with newly diagnosed type 2 diabetes
por: E. O. Melin, et al.
Publicado: (2025)

Raised levels of Interleukin‐8 and myeloperoxidase in patients with recent onset type 1 diabetes
por: Ghadeer Alhamar, et al.
Publicado: (2025)

Patterns of metformin use and glycated haemoglobin trends among patients with newly diagnosed type 2 diabetes in Alberta, Canada
por: Tina Kim, et al.
Publicado: (2024)

The effect of semaglutide on intestinal iron absorption in patients with type 2 diabetes mellitus—A pilot study
por: Petra Melis, et al.
Publicado: (2025)

Higher post‐prandial glucose excursions in youth with type 1 diabetes and celiac disease: Time to change the bolus?
por: Marco Marigliano, et al.
Publicado: (2026)

Efficacy and Safety of Olezarsen in Hypertriglyceridemia: An Updated Meta‐Analysis of Randomised Controlled Trials
por: Ahmed Emara, et al.
Publicado: (2026)

Gastric emptying in newly diagnosed, treatment‐naïve Han Chinese with type 2 diabetes and the impact of 4‐week insulin pump therapy
por: Yixuan Sun, et al.
Publicado: (2024)

The role of vitamin D in glycaemic control in patients with type 2 diabetes—A pilot D4D trial
por: Xue Fei Yu, et al.
Publicado: (2024)

Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c
por: Stephanie L. Samuels, et al.
Publicado: (2024)

Empagliflozin for the preservation of beta‐cell function in women with recent gestational diabetes: A randomized placebo‐controlled trial
por: Shamini Murugavel, et al.
Publicado: (2025)

Five‐year trajectories of HbA1c by age, sex, ethnicity and deprivation in adults with newly diagnosed type 2 diabetes: Observational study in England
por: Atanu Bhattacharjee, et al.
Publicado: (2025)

Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
por: Klemen Dovč, et al.
Publicado: (2025)

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
por: Filipe A. Moura, et al.
Publicado: (2024)

Safety and clinical effectiveness of iGlarLixi in people with type 2 diabetes mellitus in Mexico
por: Juan Rosas‐Guzman, et al.
Publicado: (2025)

Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China
por: Jing Shen, et al.
Publicado: (2025)

Genetic risk and polygenic risk score assessment of prediabetes and progression to type 2 diabetes
por: Usama Aliyu, et al.
Publicado: (2025)

Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model
por: Phil McEwan, et al.
Publicado: (2025)

Serum levels of the incretin‐like peptide 26RFa are diminished in women living with obesity and diabetes and restored after sleeve gastrectomy: Results from the prospective pilot RFa ‐Ba‐S study
por: Hind Khiar, et al.
Publicado: (2024)

Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study
por: Ernesto Maddaloni, et al.
Publicado: (2024)

Association between recent real‐life exposure to hypoglycaemia and cognitive function during hypoglycaemia in people with type 1 diabetes: Findings from the Hypo‐ RESOLVE clamp study
por: Cecilie H. Svensson, et al.
Publicado: (2025)

Hepatic thyroid hormone receptor‐β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction‐associated steatohepatitis
por: Stergios A. Polyzos, et al.
Publicado: (2024)

Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies
por: Megan Wilson, et al.
Publicado: (2024)

Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials
por: Gabriel Grando Alves, et al.
Publicado: (2024)

Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes
por: Scott A. Coon, et al.
Publicado: (2025)

The impact of vildagliptin as an add‐on therapy on matrix metalloproteinase‐14 levels, liver stiffness and subclinical atherosclerosis in adolescents with type 1 diabetes and non‐alcoholic steatohepatitis: A randomized controlled trial
por: Zeinab Anwar ElKabbany, et al.
Publicado: (2024)

Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy
por: Filipe A. Moura, et al.
Publicado: (2024)

Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
por: Tahmid Hussain, et al.
Publicado: (2026)

Association between diabetes self‐management education attendance, hospital admissions and mortality in type 2 diabetes: A cohort analysis protocol
por: Gemma A. Lewis, et al.
Publicado: (2025)

Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes
por: Jonas A. Andersen, et al.
Publicado: (2025)

Impact of glucagon‐like peptide‐1 receptor agonism‐based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta‐analysis
por: Deep Dutta, et al.
Publicado: (2025)

Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
por: Djordje S. Popovic, et al.
Publicado: (2024)

Semaglutide and MASH resolution: A pooled analysis of recent trials
por: Alaa Abdrabou Abouelmagd, et al.
Publicado: (2025)

Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study
por: Rubina Shah, et al.
Publicado: (2024)

In‐flight glycaemic control using automated insulin delivery systems: A within‐subject comparative pilot study
por: Renald Meçani, et al.
Publicado: (2025)